Health Care & Life Sciences » Pharmaceuticals | Ilsung Pharmaceutical Co. Ltd.

Ilsung Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
7,955
4,035
98,854
3,017
2,629
2,946
Depreciation, Depletion & Amortization
3,202
2,812
2,761
3,022
3,227
3,013
Other Funds
5,014
1,212
94,288
29,832
685
174
Funds from Operations
6,143
8,059
7,327
23,793
6,542
5,785
Changes in Working Capital
1,154
2,217
365
6,510
3,778
9,561
Net Operating Cash Flow
7,297
5,842
7,692
30,303
10,320
15,345
Capital Expenditures
1,127
1,076
2,848
2,772
1,850
Sale of Fixed Assets & Businesses
-
12
37
2
6
Purchase/Sale of Investments
1,336
5,528
3,109
46,321
2,273
Net Investing Cash Flow
2,446
6,544
5,842
43,561
342
Cash Dividends Paid - Total
411
336
672
1,008
1,008
Issuance/Reduction of Debt, Net
1,500
-
-
-
-
Net Financing Cash Flow
3,850
336
672
1,008
1,008
Net Change in Cash
961
1,038
1,414
12,386
9,649
Free Cash Flow
6,170
4,896
4,844
33,075
8,470
Other Sources
8
60
78
74
-
Change in Capital Stock
1,940
-
-
-
-
Exchange Rate Effect
-
40
236
137
5
Other Uses
3
-
-
64
87

About Ilsung Pharmaceutical Co.

View Profile
Address
9 Wonhyo-ro 84-gil
Seoul SL 04315
Korea, Republic Of
Employees -
Website http://www.ilsung-ph.co.kr
Updated 07/08/2019
Ilsung Pharmaceutical Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. Its products include contrast media, patches, antibiotics, antiviral agents, dermatologic agents, cardiovascular agents, antidiabetic agents, analgesics, muscle relaxants, neuropsychiatric agents, antitussives and expectorants. The company was founded by Yoon Byung-Kang in 1954 and is headquartered in Seoul, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.